&Partners’s Synopsys SNPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.34M Buy
13,430
+101
+0.8% +$45.7K 0.03% 503
2025
Q4
$6.26M Buy
13,329
+696
+6% +$309K 0.03% 425
2025
Q3
$6.25M Buy
12,633
+2,795
+28% +$1.58M 0.04% 366
2025
Q2
$5.05M Buy
9,838
+5,493
+126% +$2.56M 0.04% 367
2025
Q1
$1.91M Buy
4,345
+1,357
+45% +$659K 0.02% 558
2024
Q4
$1.48M Buy
2,988
+1,361
+84% +$711K 0.02% 605
2024
Q3
$824K Buy
1,627
+389
+31% +$209K 0.02% 648
2024
Q2
$737K Buy
1,238
+474
+62% +$268K 0.03% 424
2024
Q1
$437K Buy
+764
New +$420K 0.06% 294

Other funds holding SNPS

&Partners's SNPS Position: Q1 2026 in Review

&Partners increased its Synopsys (SNPS) stake by 0.76% in Q1 2026, buying an estimated $45.7K and bringing the position to 13,430 shares worth $5.34M. The position accounts for 0.03% of the portfolio, ranked #503.

&Partners first reported a position in SNPS in Q1 2024 and has held it in 9 quarters since. The position peaked at $6.26M in Q4 2025. 1,390 funds tracked by Wall St. Rank hold SNPS as of Q1 2026.

  • &Partners held 13,430 shares of Synopsys worth $5.34M as of Q1 2026.
  • &Partners bought 101 Synopsys shares in Q1 2026, an estimated $45.7K.
  • Synopsys made up 0.03% of &Partners's portfolio in Q1 2026, its #503 holding.
  • &Partners first reported a position in Synopsys in Q1 2024 and has held it in 9 quarters since.
  • &Partners's Synopsys position peaked at $6.26M in Q4 2025.
  • 1,390 funds tracked by Wall St. Rank held Synopsys as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.